Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate

September 15, 2014 updated by: Min Chul Cho, DongGuk University
The aim of this study was to investigate the incidence of de novo urge urinary incontinence after the photoselective vaporization of the prostate for benign prostatic hyperplasia using the validated overactive bladder symptom score, and to determine the predictors of de novo urge urinary incontinence following the photoselective vaporization of the prostate.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Min Chul Cho, M.D., Ph.D.
  • Phone Number: 7456 82-31-961-7456
  • Email: cmc1206@empal.com

Study Locations

    • Gyeonggi-do
      • Goyang, Gyeonggi-do, Korea, Republic of, 410-773
        • Recruiting
        • Dongguk University Ilsan Hospital
        • Contact:
          • Min Chul Cho, M.D., Ph.D.
          • Phone Number: 7456 82-31-961-7456
          • Email: cmc1206@empal.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

men who underwent photoselective vaporization of the prostate using 80 watt potassium-titanyl-phosphate (KTP) laser or 120 watt high-power-system (HPS) laser for benign prostatic hyperplasia refractory to medical treatment

Description

Inclusion Criteria:

  • men in whom 6-months follow-up data were available
  • men who did not complain of urge urinary incontinence based on the OABSS (overactive symptom score): OABSS question 4 score of ≤ 1

Exclusion Criteria:

  • previous prostate or bladder surgery
  • a previous diagnosis of urethral stricture or prostate carcinoma or bladder cancer or neurogenic bladder disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
photoselective vaporization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
de novo urge urinary incontinence at 6 months after surgery
Time Frame: 6 months postoperatively
de novo urge urinary incontinence: OABSS (overactive bladder symptom score) question 4 of ≥ 2
6 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Min Chul Cho, M.D., Ph.D., DongGuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Anticipated)

October 1, 2014

Study Registration Dates

First Submitted

September 13, 2014

First Submitted That Met QC Criteria

September 15, 2014

First Posted (Estimate)

September 17, 2014

Study Record Updates

Last Update Posted (Estimate)

September 17, 2014

Last Update Submitted That Met QC Criteria

September 15, 2014

Last Verified

September 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

3
Subscribe